查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864432

安氟醚市場：2025-2032年全球預測（按最終用戶、應用、產品類型和分銷管道分類）

Enflurane Market by End User, Application, Product Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，安氟醚市場規模將成長至 3.1238 億美元，複合年成長率為 4.73%。

關鍵市場統計數據
基準年 2024 2.157億美元
預計年份：2025年 2.2614億美元
預測年份 2032 3.1238億美元
複合年成長率 (%) 4.73%

基於實證醫學的恩氟烷應用：涵蓋藥理學、臨床考慮、監管進展及其對現代麻醉護理的背景影響

恩氟烷在麻醉藥理學中仍然是一種具有歷史意義和臨床價值的分子，以其中樞神經系統抑制特性和獨特的血液動力學特徵而聞名。儘管在許多情況下，新型揮發性麻醉劑已經取代了恩氟烷，但其獨特的藥理特性和已確立的臨床數據仍然影響著臨床實踐模式、監管討論和庫存決策。本文認為，恩氟烷並非過時的藥物，而是一種其當代價值受到不斷發展的安全性證據、供應鏈趨勢和不同地區監管態度影響的化合物。

要了解安氟醚在現代麻醉領域的應用，需要考慮臨床效用和風險管理之間的相互作用。產業相關人員必須權衡安氟醚已知的麻醉效果與一些潛在風險，例如高濃度下可能引發癲癇發作以及代謝物經腎臟清除等。此外，對環境永續性的日益重視正在影響吸入麻醉領域，促使人們重新關注麻醉劑的選擇和清除技術。因此，要實現精細化的應用，需要關注藥理學、臨床醫生的偏好、機構通訊協定以及其他更廣泛的因素，這些因素將決定安氟醚是繼續作為麻醉劑庫中的主力軍，還是僅限於特定用途。

臨床監測技術的進步、監管的加強、供應鏈的現代化以及對永續性的重視等變革性因素正在重塑安氟醚在醫療保健領域的使用。

安氟醚的當代應用軌跡受到多種變革性因素的影響，遠非簡單的揮發性麻醉劑選擇所致。手術全期監測和麻醉輸送系統的進步使臨床醫生能夠更精確地控制麻醉深度和生理穩定性，從而減少了對主要基於血流動力學特徵選擇的麻醉劑的依賴。同時，監管力度的加強和臨床指南的更新也改變了許多醫療中心的風險承受閾值，促使他們重新評估具有顯著神經生理特性的化合物。

此外，供應鏈的現代化和多元化正在影響醫院和診所傳統藥物的供應。隨著整合醫療系統將供應的連續性和成本可預測性置於優先地位，籌資策略擴大採用供應商冗餘和長期合約。同時，永續性的迫切需求正在重塑產品評估框架。吸入麻醉劑的生命週期評估以及回收和銷毀技術的進步，獎勵將環境影響作為處方決策的關鍵因素。這些趨勢共同作用，使得安氟醚的角色從一種廣泛使用的麻醉劑轉變為一種在臨床路徑中經過精心管理的藥物，其風險效益比仍然有利。

2025年美國關稅對恩氟烷供應連續性、採購行為、定價策略和相關人員分銷韌性的累積影響

美國2025年生效的關稅政策已在整個藥品供應鏈中造成了顯著的摩擦，恩氟烷也未能倖免。這些關稅不僅影響了藥品的單價結構，也影響了籌資策略、合約關係和庫存管理政策。為此，許多下游相關人員正在重新審視供應商多元化和近岸外包方案，以降低關稅風險和採購週期波動的影響。這些調整也正在改變供應商對麻醉劑庫存深度和前置作業時間緩衝的處理方式。

除了採購之外，關稅政策的變化也促使製造商和經銷商重新評估其定價策略和分銷網路。一些生產商正在考慮重組其生產物流以保持競爭力，而另一些生產商則在調整與中間經銷商的合約條款以保障利潤率。對於臨床醫生和醫院供應鏈管理人員而言，這些變化凸顯了事先規劃的重要性。處方委員會越來越重視供應商的韌性，並將其作為核心標準，促使他們採取更嚴格的庫存管理措施，以確保臨床照護端的持續供應。最終，2025 年關稅環境的累積影響將是增強供應端的韌性，並更加重視策略採購，這將直接影響安氟醚的供應和醫院的準備情況。

進行全面的細分分析以明確需求促進因素：整合終端用戶畫像、手術應用需求、產品類型差異和分銷管道趨勢

透過既定的細分觀點分析安氟醚，可以深入了解其需求和營運考量。每個觀點都揭示了不同的促進因素和限制因素。從最終使用者的角度來看，由於手術量、人員配置模式和藥物清單管理方面的差異，門診手術中心、診所和醫院在麻醉劑偏好上有所不同。門診機構往往優先考慮快速恢復和高效率，而診所可能更重視小型手術的成本效益通訊協定。同時，醫院必須在應對各種複雜程度的手術的同時，兼顧自身的風險管理政策。

在心血管外科、一般外科、神經外科和整形外科等不同適應症中，驅動藥物選擇的臨床需求差異顯著。心血管外科需要嚴格的血流動力學管理和多學科協作；神經外科對腦生理和癲癇閾值提出了獨特的關注；整形外科通常側重於多模式鎮痛和療效；而普通外科涵蓋廣泛的臨床頻譜，因此靈活的麻醉策略至關重要。產品類型的差異進一步增加了決策的複雜性。品牌藥和非專利藥的存在會影響採購談判、互換性認知以及監管文件。同時，對生產品質和供應可靠性的認知也會影響對某種產品類型的偏好。分銷管道的趨勢影響藥物的可及性和可獲得性。直銷關係支援大型醫療系統客製化的服務模式；包括B2B入口網站和電子商務平台在內的線上管道能夠擴大商業性覆蓋範圍；零售藥局通路（主要是連鎖藥局和獨立藥局）影響門診病人的用藥；而批發分銷仍是大規模補貨的基礎。這些環節之間的相互作用決定了安氟醚輸送的實際操作情況以及它可能被使用的臨床情況。

高解析度區域分析比較了美洲、歐洲、中東和非洲以及亞太地區在臨床應用、供應彈性和法規環境方面的差異。

區域趨勢對安氟醚的臨床相關性、供應和法規環境起著至關重要的作用，各大區域呈現出不同的模式。在美洲，機構採購慣例、報銷框架以及大型綜合醫療系統的集中化往往導致標準化的處方箋管理和集中式契約，這影響著醫院庫存中麻醉劑的種類以及在供應中斷時替代採購方案的實施速度。該地區的法律規範在於上市後監測和臨床醫生安全，這影響著安氟醚的選擇。

歐洲、中東和非洲地區呈現出多元化的格局，各國之間以及各國內部在管理體制、醫療基礎設施成熟度和採購實踐方面存在顯著差異。雖然強力的環境和永續性要求對西歐部分地區的麻醉劑政策產生了重大影響，但在中東和北非地區，藥品可近性和供應鏈韌性仍然是關鍵的營運問題。最後，亞太地區的趨勢反映了醫療服務能力的快速成長、公私服務模式的多元化以及對生產和供應鏈在地化的策略性投資。該地區在臨床實務規範和監管進展速度方面也存在差異，這些因素共同影響安氟醚在各醫療機構的評估、應用和分配方式。

對恩氟烷相關人員進行公司層面的競爭考察，重點在於供應策略、產品系列最佳化、品質透明度和臨床醫師參與方式。

與安氟醚相關企業在競爭格局上涵蓋了成熟的生產商、專業製藥公司、經銷商和臨床服務提供者。一些企業專注於精簡產品系列併提高營運效率，以確保傳統麻醉劑的持續供應；而另一些企業則優先投資於監管合規和品管，以支援與醫療系統簽訂的長期合約。各企業策略上的差異顯而易見：有些企業正在垂直整合生產和分銷環節，以降低中間環節中斷的風險；而另一些企業則在建立多元化的供應商網路，以增強自身韌性。

該領域的創新工作往往側重於配方一致性、改進包裝以提高操作性和劑量準確性，以及與醫療設備製造商合作以提高劑量和回收效率。此外，積極透過實證醫學傳播、培訓計畫和處方集支持等方式與臨床醫生互動的公司，其產品更容易獲得機構認可，並建立長期合作關係。在整個價值鏈中，生產來源的透明度、批次級可追溯性以及對品質問題的快速反應正成為影響採購決策的關鍵因素，尤其對於大型醫院系統和採購聯盟而言更是如此。

為製造商、經銷商和醫療保健提供者提供切實可行的建議，以增強供應鏈韌性、吸引臨床醫生參與、融入永續性並最佳化分銷策略。

產業領導者若想在不斷變化的安氟醚市場中有效定位自身，應採取一系列切實可行的措施，協調商業性、臨床和營運方面的優先事項。首先，應優先考慮供應商的韌性，透過多元化採購管道和協商合約機制，確保能夠靈活調整供應量以應對需求波動。其次，應積極與臨床相關人員互動，資助有針對性的教育和證據審查，以闡明安氟醚在特定外科適應症中的比較優勢和風險管理通訊協定。這些臨床醫生的措施將有助於建立信任，並促進有關處方集的建設性討論。

第三，我們將建構兼顧環境影響的產品價值提案，具體做法是記錄產品生命週期的環境影響，並在適用情況下支持回收和廢棄物處理技術的投資。第四，我們將加強品管和可追溯性能力。生產資料和批次級文件的透明化將減少採購摩擦，並有助於符合監管要求。第五，我們將重新評估分銷策略，將直接銷售給關鍵客戶與強大的線上和批發夥伴關係相結合，旨在確保在各種醫療機構中都能獲得產品。最後，我們將保持積極的監管溝通，預測政策變化並參與指南制定，從而影響決策者對安氟醚的評估標準。

這項關於恩氟烷的分析以穩健的調查方法為基礎，該方法說明了證據三角測量、專家檢驗、定性綜合和基於情境的壓力測試。

本分析採用系統性的調查方法，整合了多方面的證據，強調資訊來源三角驗證、專家檢驗和情境解讀。主要資料來源包括同儕審查的臨床文獻、監管指導文件以及從採購從業人員和生產相關人員收集的匿名供應鏈資訊。次要資料來源包括白皮書、麻醉劑給藥和清除方面的技術指南，以及已在其處方集決策過程中評估過安氟醚的機構提供的營運案例研究。

為確保研究結果的穩健性，我們將對臨床醫生和供應鏈管理人員的訪談定性結果與監管文件和生產品質資訊進行了交叉比對。分析程序包括對定性資料進行主題編碼、建立情境圖以探索政策和採購變更的影響，以及根據已記錄的關稅和物流變更對供應鏈假設進行壓力測試。研究結果由麻醉師、藥劑師和採購負責人組成的專家評審小組進行檢驗，以確認其實際意義並完善建議。在整個過程中，我們始終保持假設和證據來源的透明性，以確保研究結果的可重複性，並便於在報告後的諮詢服務中為客戶提供客製化服務。

對製造商、醫療保健提供者和政策制定者而言，本報告旨在全面綜合戰略意義，以確保在安氟醚相關決策中，能夠做出合理、以患者為中心且具有營運韌性的決策。

總之，安氟醚在現代麻醉護理中佔據著微妙的地位。儘管在許多情況下其常規使用有所減少，但當其特定的藥理特性與臨床需求相符時，它仍然效用。監管的關注、永續性問題以及供應鏈壓力共同促使人們重新定義麻醉劑處方清單的選擇和維持標準。因此，相關人員必須權衡臨床療效與供應穩定性、環境影響和組織風險接受度等因素。

展望未來，供應商多元化、臨床醫生參與和透明的品管等策略性舉措將決定安氟醚在手術全期護理中的地位。政策制定者和機構領導者應優先考慮以實證醫學為基礎的指南制定和採購政策，並將營運實際情況和環境因素納入考量。透過協調臨床通訊協定、籌資策略以及與監管機構的對話，相關人員可以確保有關安氟醚的決策具有合理性、以患者為中心且在營運上永續。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 一系列監管審查評估了氟烷排放對環境的影響
  • 人們對專為資源匱乏的手術中心訂製的安氟醚製劑越來越感興趣
  • 引進一種新型閉路麻醉劑輸送系統以減少安氟醚的消費量
  • 非專利藥生產商與OEM供應商建立新的合作夥伴關係，旨在擴大安氟醚在亞洲的供應。
  • 門診癌症患者鎮靜和疼痛管理通訊協定中安氟醚應用的臨床調查
  • 替代性氟化麻醉劑日益激烈的價格競爭對安氟醚在歐洲的市佔率構成挑戰。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依最終用戶分類的安氟醚市場

  • 門診手術中心
  • 診所
  • 醫院

第9章安氟醚市場應用

  • 心血管外科
  • 一般外科
  • 神經外科
  • 整形外科手術

第10章 安氟醚市場（依產品類型分類）

  • 品牌產品
  • 非專利的

第11章安氟醚市場（按分銷管道）

  • 直銷
  • 線上
    • B2B入口網站
    • 電子商務平台
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房
  • 批發的

第12章 各地區安氟醚市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 安氟醚市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國安氟醚市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • Piramal Enterprises Limited
    • Hikma Pharmaceuticals PLC
    • Baxter International Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sandoz International GmbH
    • Viatris Inc.
    • Hetero Labs Limited
Product Code: MRR-F97DD5A7D999

The Enflurane Market is projected to grow by USD 312.38 million at a CAGR of 4.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 215.70 million
Estimated Year [2025] USD 226.14 million
Forecast Year [2032] USD 312.38 million
CAGR (%) 4.73%

An evidence-based introduction to enflurane covering pharmacology, clinical considerations, regulatory dynamics, and contextual relevance for contemporary anesthesia practice

Enflurane remains a molecule of historical and clinical interest within the anesthetic pharmacopeia, recognized for its central nervous system depressant properties and particular hemodynamic profile. Although newer volatile agents have eclipsed enflurane in many settings, its unique pharmacologic characteristics and established clinical data continue to inform practice patterns, regulatory conversations, and inventory decisions. This introduction frames enflurane not as a relic but as a compound whose present-day relevance is shaped by evolving safety evidence, supply chain dynamics, and divergent regional regulatory postures.

To understand enflurane's contemporary footprint, it is essential to consider the interplay of clinical utility and risk management. Industry stakeholders must weigh enflurane's known anesthetic effects against concerns such as seizure risk at high concentrations and renal handling of its metabolites. Moreover, the landscape of inhalational anesthesia has been influenced by growing emphasis on environmental sustainability, which has redirected attention to agent selection and scavenging technology. Consequently, a nuanced introduction requires attention to pharmacology, clinician preference, institutional protocols, and the broader forces that determine whether enflurane remains an active component of anesthetic formularies or is relegated to specialized roles.

Transformative forces including clinical monitoring advances, regulatory tightening, supply chain modernization, and sustainability priorities reshaping enflurane utilization across care settings

The contemporary trajectory of enflurane utilization is being shaped by multiple transformative shifts that go beyond simple preferences for one volatile agent over another. Advances in perioperative monitoring and anesthesia delivery systems have enabled clinicians to target anesthetic depth and physiological stability with greater precision, reducing reliance on agents selected primarily for their hemodynamic profiles. Simultaneously, heightened regulatory scrutiny and updated clinical guidance have altered risk tolerance thresholds in many institutions, prompting a reevaluation of compounds with distinct neurophysiologic signatures.

Furthermore, supply chain modernization and procurement diversification are influencing how hospitals and clinics maintain access to legacy agents. As integrated healthcare systems prioritize supply continuity and cost predictability, purchasing strategies increasingly incorporate supplier redundancy and longer-term contracting. In parallel, sustainability imperatives are reframing product evaluation; life-cycle assessments of inhalational agents and advances in scavenging and destruction technologies have created incentives to consider environmental impact as a material input in formulary decision-making. Taken together, these trends are catalyzing a shift in enflurane's role from a broadly available anesthetic to a component whose use is deliberately managed within clinical pathways where its risk-benefit calculus remains favorable.

Cumulative implications of the 2025 United States tariff measures on enflurane supply continuity, procurement behaviors, pricing strategies, and distribution resilience across stakeholders

The tariff actions enacted in the United States during 2025 have introduced measurable frictions across pharmaceutical supply chains, and enflurane has not been immune to these effects. Tariffs influence not only unit cost structures but also sourcing strategies, contractual relationships, and inventory policies. In response, many downstream stakeholders have revisited supplier diversity and nearshoring options to mitigate exposure to tariffs and the volatility they can introduce into procurement cycles. These adaptive behaviors, in turn, change how providers approach stocking depth and lead-time buffers for anesthesia agents.

Beyond procurement, tariff-induced changes have prompted manufacturers and distributors to reassess pricing strategies and distribution footprints. Some producers have explored reconfiguration of manufacturing logistics to preserve competitiveness, while others have adjusted contractual terms with intermediate distributors to protect margins. For clinicians and hospital supply chain managers, these shifts have underscored the importance of anticipatory planning: formulary committees increasingly consider supplier resilience as a core criterion, and inventory governance practices have tightened to ensure uninterrupted clinical availability. Ultimately, the cumulative effect of the 2025 tariff environment is a heightened emphasis on supply-side robustness and strategic sourcing that directly affect enflurane accessibility and institutional preparedness.

Comprehensive segmentation insights integrating end user profiles, surgical application needs, product type distinctions, and distribution channel dynamics to clarify demand determinants

A granular view of demand and operational considerations emerges when enflurane is analyzed through established segmentation lenses, each of which reveals distinct drivers and constraints. When examined by end user, differences in procedural volume, staffing models, and formulary governance mean that ambulatory surgery centers, clinics, and hospitals exhibit divergent preferences for anesthetic agents; ambulatory settings often prioritize rapid recovery and throughput, clinics may emphasize cost-effective protocols for minor procedures, and hospitals must balance a broader range of surgical complexity with institutional risk policies.

Looking across application areas such as cardiovascular surgery, general surgery, neurosurgery, and orthopedic surgery, the clinical imperatives that inform agent selection vary substantially. Cardiovascular procedures demand strict hemodynamic control and multispecialty coordination, neurosurgery raises unique concerns about cerebral physiology and seizure thresholds, orthopedic surgery frequently focuses on multimodal analgesia and efficiency, and general surgery encompasses a wide clinical spectrum that necessitates flexible anesthetic strategies. Product-type segmentation further complicates decision-making: the presence of branded and generic options influences procurement negotiations, perceived interchangeability, and regulatory documentation, while perceptions about manufacturing quality and supply reliability can drive preference for one product type over another. Distribution channel dynamics shape availability and access; direct sales relationships support tailored service models for large health systems, online channels including B2B portals and e-commerce platforms enable broader commercial reach, retail pharmacy pathways structured around chain and independent pharmacies affect outpatient accessibility, and wholesale distribution remains a backbone for large-scale replenishment. Interactions among these segments determine both the operational realities of supplying enflurane and the clinical contexts in which it is likely to be used.

High-resolution regional analysis comparing Americas, Europe Middle East & Africa, and Asia-Pacific differences in clinical adoption, supply resilience, and regulatory environments

Regional dynamics play a defining role in enflurane's clinical relevance, supply arrangements, and regulatory environment, with distinct patterns observable across major geographies. In the Americas, institutional procurement practices, reimbursement frameworks, and a concentration of large integrated health systems often lead to standardized formulary governance and centralized contracting, influencing which anesthetic agents are maintained on hospital shelves and how quickly alternative sourcing can be enacted when disruptions occur. Regulatory oversight in this region emphasizes post-market surveillance and clinician safety, shaping the conditions under which enflurane is selected.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory regimes, healthcare infrastructure maturity, and procurement modalities vary widely between and within countries. In several Western European jurisdictions, strong environmental and sustainability mandates exert a material influence on anesthetic agent policy, while in parts of the Middle East and Africa, access and supply chain resilience remain primary operational concerns. Finally, Asia-Pacific dynamics reflect rapid healthcare capacity expansion, a diverse mix of public and private service delivery models, and strategic investments in manufacturing and supply chain localization. This region also exhibits differing clinical practice norms and regulatory tempos, which together determine how enflurane is evaluated, adopted, and distributed across facilities.

Company-level competitive insights emphasizing supply strategies, portfolio optimization, quality transparency, and clinician engagement approaches among enflurane stakeholders

Competitive positioning among companies involved with enflurane spans legacy producers, specialty pharmaceutical manufacturers, distributors, and clinical services providers. Several organizations have focused on portfolio rationalization and operational efficiency to maintain supply continuity for older anesthetic agents, while others have prioritized investments in regulatory compliance and quality control to support long-term contracting with health systems. Distinct strategies have emerged: some firms emphasize vertical integration of manufacturing and distribution to reduce exposure to intermediated disruptions, whereas others cultivate diversified supplier networks to achieve resilience.

Innovation efforts in the sector are often concentrated on formulation consistency, packaging improvements that enhance handling and dosing accuracy, and collaborations with device makers to improve delivery and scavenging. Additionally, companies that proactively engage with clinicians through evidence dissemination, training programs, and formulary support tend to secure stronger institutional adoption and long-term contractual relationships. Across the value chain, transparency about manufacturing provenance, lot-level traceability, and responsiveness to quality inquiries has become a differentiator that influences purchasing decisions, particularly among large hospital systems and purchasing consortia.

Actionable recommendations for manufacturers, distributors, and healthcare providers to fortify supply resilience, engage clinicians, incorporate sustainability, and optimize distribution strategies

Industry leaders seeking to position themselves effectively in the evolving enflurane landscape should adopt a set of pragmatic, actionable measures that align commercial, clinical, and operational priorities. First, prioritize supplier resilience by diversifying sourcing and negotiating contractual mechanisms that provide supply guarantees and flexibility to adjust volume commitments in response to demand variability. Second, engage proactively with clinical stakeholders by funding targeted education and evidence reviews that clarify enflurane's comparative benefits and risk management protocols for specific surgical applications. These clinician-facing efforts will build trust and facilitate constructive formulary discussions.

Third, incorporate environmental impact considerations into product value propositions by documenting life-cycle footprints and supporting investments in scavenging and destruction technologies where applicable. Fourth, strengthen quality and traceability capabilities: transparent manufacturing data and lot-level documentation reduce procurement friction and support regulatory compliance. Fifth, reassess distribution strategies to include a mix of direct sales for key accounts and robust online and wholesale partnerships to preserve access across diverse care settings. Finally, maintain active regulatory engagement to anticipate policy shifts and to participate in guideline development, thereby influencing the terms under which enflurane is evaluated by decision-makers.

Robust research methodology describing evidence triangulation, expert validation, qualitative synthesis, and scenario-based stress testing used to underpin the enflurane analysis

This analysis synthesizes multiple evidence streams using a structured methodology that emphasizes source triangulation, expert validation, and contextual interpretation. Primary inputs include peer-reviewed clinical literature, regulatory guidance documents, and anonymized supply chain intelligence drawn from procurement practitioners and manufacturing stakeholders. Secondary inputs encompass white papers, technical guidance on anesthesia delivery and scavenging, and operational case studies from institutions that have evaluated enflurane within formulary decision processes.

To ensure robustness, qualitative insights from clinician interviews and supply chain managers were cross-referenced with regulatory documents and manufacturing quality information. Analytical steps included thematic coding of qualitative data, scenario mapping to explore implications of policy and procurement shifts, and stress-testing of supply chain assumptions against documented tariff and logistics changes. Findings were validated through expert review panels comprising anesthesiologists, pharmacists, and procurement leaders to confirm practical relevance and to refine recommendations. Throughout the process, transparency about assumptions and evidence sources was maintained to support reproducibility and to facilitate client-specific customization during post-report advisory engagements.

Concluding synthesis of strategic implications for manufacturers, healthcare providers, and policymakers aimed at ensuring defensible, patient-centered, and operationally resilient decisions about enflurane

In conclusion, enflurane occupies a nuanced position in contemporary anesthesia practice: while its routine use has declined in many settings, it retains potential utility where specific pharmacologic attributes align with clinical needs. The convergence of regulatory attention, sustainability concerns, and supply chain pressures has redefined the criteria by which anesthetic agents are selected and maintained on formularies. Consequently, stakeholders must balance clinical efficacy with considerations of supply resilience, environmental footprint, and institutional risk tolerance.

Moving forward, strategic attention to supplier diversification, clinician engagement, and transparent quality practices will determine how enflurane figures into perioperative care pathways. Policymakers and institutional leaders should prioritize evidence-informed guideline development and procurement policies that incorporate operational realities and environmental considerations. By aligning clinical protocols, procurement strategies, and regulatory dialogue, stakeholders can ensure that decisions about enflurane are defensible, patient-centered, and operationally sustainable.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Spate of regulatory reviews assessing environmental impact of enflurane emissions
  • 5.2. Growing interest in enflurane formulations tailored for low-resource surgery centers
  • 5.3. Integration of new closed-circuit anesthetic delivery systems to reduce enflurane consumption
  • 5.4. Emerging partnerships between generic manufacturers and OEM suppliers to expand enflurane access in Asia
  • 5.5. Clinical research exploring enflurane use in outpatient oncology sedation and pain management protocols
  • 5.6. Accelerated price competition from alternative fluorinated anesthetics challenging enflurane market share in Europe

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enflurane Market, by End User

  • 8.1. Ambulatory Surgery Centers
  • 8.2. Clinics
  • 8.3. Hospitals

9. Enflurane Market, by Application

  • 9.1. Cardiovascular Surgery
  • 9.2. General Surgery
  • 9.3. Neurosurgery
  • 9.4. Orthopedic Surgery

10. Enflurane Market, by Product Type

  • 10.1. Branded
  • 10.2. Generic

11. Enflurane Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online
    • 11.2.1. B2B Portals
    • 11.2.2. E-Commerce Platforms
  • 11.3. Retail Pharmacy
    • 11.3.1. Chain Pharmacy
    • 11.3.2. Independent Pharmacy
  • 11.4. Wholesale

12. Enflurane Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enflurane Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enflurane Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Fresenius Kabi AG
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. Piramal Enterprises Limited
    • 15.3.5. Hikma Pharmaceuticals PLC
    • 15.3.6. Baxter International Inc.
    • 15.3.7. Teva Pharmaceutical Industries Ltd.
    • 15.3.8. Sandoz International GmbH
    • 15.3.9. Viatris Inc.
    • 15.3.10. Hetero Labs Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENFLURANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENFLURANE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENFLURANE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENFLURANE MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENFLURANE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENFLURANE MARKET SIZE, BY BRANDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENFLURANE MARKET SIZE, BY GENERIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENFLURANE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENFLURANE MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENFLURANE MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENFLURANE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENFLURANE MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENFLURANE MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENFLURANE MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ENFLURANE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ENFLURANE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 249. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GCC ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GCC ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. GCC ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. GCC ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. GCC ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. GCC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. GCC ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. GCC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. GCC ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. GCC ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 260. GCC ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 261. GCC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 291. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. G7 ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. G7 ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. G7 ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. G7 ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. G7 ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. G7 ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. G7 ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. G7 ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 300. G7 ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 301. G7 ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 302. G7 ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 303. G7 ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 305. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. NATO ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. NATO ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. NATO ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. NATO ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NATO ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. NATO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. NATO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. NATO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. NATO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. NATO ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 316. NATO ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 317. NATO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 318. NATO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED STATES ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED STATES ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED STATES ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED STATES ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED STATES ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED STATES ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED STATES ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 333. CANADA ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. CANADA ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. CANADA ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. CANADA ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. CANADA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. CANADA ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. CANADA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 340. CANADA ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 341. CANADA ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 342. CANADA ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 343. CANADA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 344. CANADA ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 345. MEXICO ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 346. MEXICO ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 347. MEXICO ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. MEXICO ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. MEXICO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. MEXICO ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. MEXICO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 352. MEXICO ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 353. MEXICO ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 354. MEXICO ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 355. MEXICO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 356. MEXICO ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 357. BRAZIL ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. BRAZIL ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. BRAZIL ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 360. BRAZIL ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 361. BRAZIL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. BRAZIL ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 363. BRAZIL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 364. BRAZIL ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 365. BRAZIL ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 366. BRAZIL ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 367. BRAZIL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 368. BRAZIL ENFLURANE MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 369. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 370. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 371. UNITED KINGDOM ENFLURANE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 372. UNITED KINGDOM ENFLURANE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 373. UNITED KINGDOM ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. UNITED KINGDOM ENFLURANE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 375. UNITED KINGDOM ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 376. UNITED KINGDOM ENFLURANE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 377. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 378. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
  • TABLE 379. UNITED KINGDOM ENFLURANE MARKET SIZE, BY RE